SCHEMBL13870932

SCHEMBL13870932

COc1cc2nc(-c3cc(C)cc(C)c3)ccc2c(OC)c1OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 2/20 0.44
BRD4 O60885 1/20 0.43
PDGFRB P09619 2/20 0.42
PDGFRA P16234 2/20 0.42
ACHE P22303 1/20 0.42
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
TDO2 P48775 1/20 0.40
ALDH1A1 P00352 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
KDM4E B2RXH2 3/20 0.40
SLC10A2 Q12908 2/20 0.40
PSMB5 P28074 1/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
SLC2A1 P11166 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
GAA P10253 2/20 0.38
WHR1 P49842 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13870933 0.87 ALDH1A1 (0.48) MAOABRD4TDO2ALDH1A1SMN1; SMN2
SCHEMBL13870820 0.83 KDM4E (0.49) PDGFRBPDGFRAACHEPDE3BPDE3A
SCHEMBL13870944 0.83 KATNA1 (0.44) MAOABRD4PDGFRBPDGFRAPDE3B
SCHEMBL1337819 0.82 KDM4E (0.54) MAOAPDGFRBPDGFRAACHETDO2
SCHEMBL16487818 0.82 RAB9A (0.34) BRD4TDO2ALDH1A1SMN1; SMN2KDM4E
SCHEMBL13870818 0.81 TDO2 (0.41) BRD4TDO2ALDH1A1SMN1; SMN2KDM4E
SCHEMBL13870922 0.80 ALDH1A1 (0.50) BRD4PDGFRBPDGFRAPDE3BPDE3A
SCHEMBL13870911 0.79 KDM4E (0.56) PDGFRBPDGFRAPDE3BPDE3ATDO2
SCHEMBL13870941 0.79 SMN1; SMN2 (0.52) MAOAPDGFRBPDGFRATDO2ALDH1A1
SCHEMBL1338049 0.79 PDGFRB (0.51) MAOAPDGFRBPDGFRATDO2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-8956737-B2 Red phosphorescent compound and organic electroluminescent device using the same LG DISPLAY CO., LTD. (KR) 2015-02-17 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME LG DISPLAY CO., LTD. (KR) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090085476-A1 RED PHOSPHORESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME IK, G6PD, EYA2 MAOA 3884/4885BRD4 3694/4885PDGFRB 1748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.